Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Atara Biotherapeutics (ATRA) Cost of Revenue (2023 - 2026)

Atara Biotherapeutics filings provide 4 years of Cost of Revenue readings, the most recent being $124000.0 for Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 99.39% to $124000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $897000.0, a 97.73% decrease, with the full-year FY2025 number at $21.2 million, up 0.97% from a year prior.
  • Cost of Revenue hit $124000.0 in Q1 2026 for Atara Biotherapeutics, up from $104000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $20.4 million in Q1 2025 to a low of $104000.0 in Q4 2025.
  • Median Cost of Revenue over the past 4 years was $2.6 million (2023), compared with a mean of $3.9 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 929.67% in 2025 and later crashed 99.39% in 2026.
  • Atara Biotherapeutics' Cost of Revenue stood at $3.2 million in 2023, then skyrocketed by 115.03% to $6.8 million in 2024, then tumbled by 98.47% to $104000.0 in 2025, then rose by 19.23% to $124000.0 in 2026.
  • The last three reported values for Cost of Revenue were $124000.0 (Q1 2026), $104000.0 (Q4 2025), and $115000.0 (Q3 2025) per Business Quant data.